Acrivon Therapeutics, Inc. (ACRV)
NASDAQ: ACRV · Real-Time Price · USD
1.730
+0.040 (2.37%)
At close: Aug 7, 2026, 4:00 PM EDT
1.740
+0.010 (0.58%)
After-hours: Aug 7, 2026, 4:36 PM EDT
Acrivon Therapeutics Market Cap
Acrivon Therapeutics has a market cap or net worth of $74.05 million as of August 7, 2026. Its market cap has increased by 83.07% in one year.
Market Cap
74.05M
Enterprise Value
-23.42M
1-Year Change
83.07%
Ranking
Category
Stock Price
$1.73
ChartMarket Cap Chart
Since the IPO on November 15, 2022, Acrivon Therapeutics's market cap has decreased from $235.12M to $74.05M, a decrease of -68.51%. That is a compound annual growth rate of -26.65%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 74.05M | -2.63% |
| Dec 31, 2025 | 76.05M | -59.43% |
| Dec 31, 2024 | 187.44M | 71.66% |
| Dec 29, 2023 | 109.20M | -54.61% |
| Dec 30, 2022 | 240.59M | 2.33% |
| Nov 15, 2022 | 235.12M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Elicio Therapeutics | 74.81M |
| Champions Oncology | 73.64M |
| Spero Therapeutics | 73.53M |
| Eloxx Pharmaceuticals | 72.17M |
| LeonaBio | 71.58M |
| OS Therapies | 71.26M |
| iBio, Inc. | 69.55M |
| XBiotech | 68.90M |